Replies to post #525 on Gamida Cell Ltd (fka GMDAQ)

[midastouch017]

maybe to your point sentiment is more positive by the investment community?

For sure! Unless the concern about the raise and
the difficulty to do so at present gave the negative
sentiment as relfected in the sp the price would
have been much higher.

there would be a little run up to $2.00 prior to May 1.

Perhaps not $2.00 but $1.75 is feasible.

All of us in a wait and see mode for sure!!

Fingers crossed and good fortune.

:-)

[midastouch017]

Gamida cell therapy Omisirge for blood cancer patients approved by FDA

Apr. 17, 2023 1:51 PM ET
Gamida Cell Ltd. (GMDA)
By: Jonathan Block, SA News Editor2

The US FDA has approved Omisirge (omidubicel-onlv), an allogeneic blood-based cell therapy from Gamida Cell Ltd. (NASDAQ:GMDA) for patients with blood cancers to be used before umbilical cord blood transplants.
The stock is up 34% in Monday afternoon trading.